Showing results (21-30 of 279) with videos related to
Sort By:
Pageof 28
European Annals of Allergy and Clinical Immunology|May 13, 2017
Disappearance of severe oral allergy syndrome following omalizumab treatmentR AseroEuropean Annals of Allergy and Clinical Immunology|February 4, 2011
Co-recognition of lipid trasfer protein in pollen and foods in northern Italy: clinician's viewR AseroEuropean Annals of Allergy and Clinical Immunology|February 1, 2018
Restoration of aspirin tolerance following omalizumab treatment in a patient with chronic spontaneous urticariaR AseroJournal of Investigational Allergology & Clinical Immunology|November 24, 2004
Analysis of new respiratory allergies in patients monosensitized to airborne allergens in the area north of MilanR AseroEuropean Annals of Allergy and Clinical Immunology|October 10, 2019
Severe CSU and activation of the coagulation/fibrinolysis system: clinical aspectsR AseroClinical and Experimental Dermatology|October 24, 2007
Etoricoxib challenge in patients with chronic urticaria with NSAID intoleranceR AseroAnnals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 12, 2000
Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticariaR AseroCurrent Allergy Reports|March 20, 2002
Multiple drug allergy syndrome: a distinct clinical entityR AseroEuropean Annals of Allergy and Clinical Immunology|September 11, 2020
Omalizumab in severe chronic urticaria: are slow and non-responders different?R AseroEuropean Annals of Allergy and Clinical Immunology|March 18, 2011
Hypersensitivity to lipid transfer protein is frequently associated with chronic urticariaR AseroPageof 28